D.E. Shaw & Co’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-23,000
Closed -$3.56M 6095
2021
Q4
$3.56M Sell
23,000
-10,000
-30% -$1.67M ﹤0.01% 2771
2021
Q3
$5.6M Hold
33,000
0.01% 2002
2021
Q2
$5.21M Hold
33,000
﹤0.01% 1996
2021
Q1
$4.58M Sell
33,000
-10,600
-24% -$1.71M ﹤0.01% 1913
2020
Q4
$7.64M Hold
43,600
0.01% 1546
2020
Q3
$8.53M Sell
43,600
-1,600
-4% -$268K 0.01% 1343
2020
Q2
$7.68M Buy
45,200
+12,400
+38% +$1.85M 0.01% 1356
2020
Q1
$3.78M Hold
32,800
0.01% 1670
2019
Q4
$3.75M Buy
+32,800
New +$3.48M ﹤0.01% 1969
2014
Q1
Sell
-40,000
Closed -$1.6M 4717
2013
Q4
$1.6M Hold
40,000
﹤0.01% 2745
2013
Q3
$1.75M Buy
+40,000
New +$1.67M ﹤0.01% 2533

Other funds holding SGEN

D.E. Shaw & Co's SGEN Position: Q4 2023 in Review

D.E. Shaw & Co sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 878,991 shares — an estimated $186M sold.

D.E. Shaw & Co first reported a position in SGEN in Q2 2013 and held it in 38 quarters. The position peaked at $186M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • D.E. Shaw & Co reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 878,991 Seagen Inc. Common Stock shares in Q4 2023, an estimated $186M.
  • D.E. Shaw & Co first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 38 quarters.
  • D.E. Shaw & Co's Seagen Inc. Common Stock position peaked at $186M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.